Paperpal Prime Logo

Journal of Neurology : Impact Factor & More

eISSN: 1432-1459pISSN: 0340-5354

Key Metrics

CiteScore
7.6
H-Index
152
Impact Factor
5 - 10
Scite Index
0.86 5-Year SI
SJR
Q1Neurology
SNIP
1.76
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Neurology

Journal of Neurology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher SPRINGER HEIDELBERG
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1891
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Neurology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Neurology

Genome-wide spectrum of coding DNA variations in Indian patients with amyotrophic lateral sclerosis.
  • 1 Jul 2026
  • Journal of neurology
Number needed to treat and harm for lecanemab and donanemab in early Alzheimer disease.
  • 1 Jul 2026
  • Journal of neurology
Triple-crush mechanism in multiple sclerosis-associated trigeminal neuralgia.
  • 29 Jun 2026
  • Journal of neurology
Efficacy and safety of ofatumumab in participants with relapsing multiple sclerosis and breakthrough disease on oral fingolimod or fumarates: results from the ARTIOS study.
  • 29 Jun 2026
  • Journal of neurology
Quantification of amyotrophic lateral sclerosis (ALS) disease accumulation with T1-weighted high-resolution magnetic resonance imaging: validation in an independent cohort.
  • 29 Jun 2026
  • Journal of neurology
Genetic spectrum and clinical features of PMP22 point mutations in Japanese Charcot-Marie-Tooth disease.
  • 29 Jun 2026
  • Journal of neurology
Genome-wide spectrum of coding DNA variations in Indian patients with amyotrophic lateral sclerosis.
  • 1 Jul 2026
  • Journal of neurology
Number needed to treat and harm for lecanemab and donanemab in early Alzheimer disease.
  • 1 Jul 2026
  • Journal of neurology
Triple-crush mechanism in multiple sclerosis-associated trigeminal neuralgia.
  • 29 Jun 2026
  • Journal of neurology
Efficacy and safety of ofatumumab in participants with relapsing multiple sclerosis and breakthrough disease on oral fingolimod or fumarates: results from the ARTIOS study.
  • 29 Jun 2026
  • Journal of neurology
Quantification of amyotrophic lateral sclerosis (ALS) disease accumulation with T1-weighted high-resolution magnetic resonance imaging: validation in an independent cohort.
  • 29 Jun 2026
  • Journal of neurology
Genetic spectrum and clinical features of PMP22 point mutations in Japanese Charcot-Marie-Tooth disease.
  • 29 Jun 2026
  • Journal of neurology

FAQs on Journal of Neurology